| Financial Year |
March 31 2023 |
| Monetary Funds |
461,030,424.19 |
| Held-for-trading Financial Assets |
119,666,530.15 |
| Notes Receivable |
-- |
| Accounts Receivable |
268,129,039.98 |
| Advances to Suppliers |
15,152,928.27 |
| Other Receivables |
3,165,147.45 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
359,851,031.46 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
5,821,254.94 |
| Total Current Assets |
1,282,216,638.54 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
1,171,023.48 |
| Fixed Assetes |
542,614,172.00 |
| Under-construction Projects |
146,762,813.16 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
136,463,743.22 |
| R&D expenses |
-- |
| Goodwill |
28,531,088.84 |
| Long-Term Deferred and Prepaid Expenses |
13,762,295.88 |
| Deferred Income Tax Assets |
17,929,808.79 |
| Other Non-Current Assets |
34,245,462.61 |
| Sub-Total of Non-Current Assets |
947,528,315.86 |
| Total Assets |
2,229,744,954.40 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
138,650,000.00 |
| Accounts Payable |
221,700,529.37 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
12,971,965.86 |
| Taxes Payable |
22,942,872.14 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
31,893,285.05 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,110,097.50 |
| Other Current Liabilities |
168,704.11 |
| Sub-Total of Current Liabilities |
433,063,923.96 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
9,494,262.66 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
54,233,920.05 |
| Total Liabilities |
487,297,844.01 |
| Paid-In Capital(Or Share Stock) |
254,254,250.00 |
| Capital Surplus |
95,560,100.22 |
| Surplus Reserve |
111,135,898.56 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,004,363,116.92 |
| Minority Stockholder's Interest |
277,133,744.69 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,465,313,365.70 |
| Owner's Equity（Stockholder's Equity） |
1,742,447,110.39 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,229,744,954.40 |
